Answer
Beta-blockers may weaken or antagonise the effect of olodaterol in Spiolto Respimat; cardioselective beta-blockers may be considered but should be used with caution.
Sources for this answer
- Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solutionBoehringer Ingelheim Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 9Document updated
Sources checked